Abstract
Loss of cell cycle regulation in mammary epithelium results in impaired mammary gland development and neoplasia. We investigated the consequences of the absence of pRb in mammary epithelial cells during normal development and in mice that express an oncogene in the mammary epithelium. Since pRb-deficiency results in embryonic lethality, we transplanted pRb-null mammary anlagen into wild hosts. pRb-deficient mammary epithelia were capable of functional differentiation in term animals and they regenerated a differentiated gland even after multiple pregnancies. In serial transplantations no significant differences were found in outgrowth of pRb-deficient and wild type epithelia indicating that the absence of pRb does not lead to transformation. Likewise the effect of a TGFβ1 transgene was not altered in the absence of pRb. The susceptibility of mammary epithelium to form tumors was assessed in three different models. No differences in tumor incidence were found between wild type and Rb +/− WAP-int3, MMTV-PyMT transgenic and Brcal−/− epithelia. These results demonstrate that the absence of pRb does not affect normal mammary gland development and tumorigenesis in three different mouse models investigated and suggest that loss of more than one member of the pRb pathway is required to induce mammary tumors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Aprelikova ON, Fang BS, Meissner EG, Cotter S, Campbell M, Kuthiala A, Bessho M, Jensen RA, Liu ET . 1999 Proc. Natl. Acad. Sci. USA 96: 11866–11871
Chomczynski P, Sacchi N . 1987 Anal. Biochem. 162: 156–159
Classon M, Kennedy BK, Mulloy R, Harlow E . 2000 Proc. Natl. Acad. Sci. USA 97: 10826–10831
Daniel CW, DeOme KB, Young JT, Blair PB, Faulkin Jr LJ . 1968 Proc. Natl. Acad. Sci. USA 61: 53–60
Dannenberg JH, van Rossum A, Schuijff L, te Riele H . 2000 Genes Dev. 14: 3051–3064
DeOme KB, Faulkin Jr LJ, Bern HA, Blair PE . 1959 Cancer Res. 19: 515–520
Dublin EA, Patel NK, Gillett CE, Smith P, Peters G, Barnes DM . 1998 Int. J. Cancer 79: 71–75
Gallahan D, Jhappan C, Robinson G, Hennighausen L, Sharp R, Kordon E, Callahan R, Merlino G, Smith GH . 1996 Cancer Res. 56: 1775–1785
Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C . 1998 Am. J. Pathol. 153: 1749–1765
Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ . 1992 Proc. Natl. Acad. Sci. USA 89: 10578–10582
Herrera RC, Sah VP, Williams BO, Makela TP, Weinberg RA, Jacks T . 1996 Mol. Cell. Biol. 16: 2402–2407
Hu N, Gutsmann A, Herbert DC, Bradley A, Lee WH, Lee EY . 1994 Oncogene 9: 1021–1027
Jhappan C, Geiser AG, Kordon EC, Bagheri D, Hennighausen L, Roberts AB, Smith GH, Merlino G . 1993 EMBO J. 12: 1835–1845
Kordon EC, McKnight RA, Jhappan C, Hennighausen L, Merlino G, Smith GH . 1995 Dev. Biol. 168: 47–61
Lee EY, Chang CY, Hu N, Wang YC, Lai CC, Herrup K, Lee WH, Bradley A . 1992 Nature 359: 288–294
Li M, Hu J, Heermeier K, Hennighausen L, Furth PA . 1996 Cell Growth Differ. 7: 3–11
Maandag EC, van der Valk M, Vlaar M, Feltkamp C, O'Brien J, van Roon M, van der Lugt N, Berns A, te Riele H . 1994 EMBO J. 13: 4260–4268
Maroulakou IG, Anver M, Garrett L, Green JE . 1994 Proc. Natl. Acad. Sci. USA 91: 11236–11240
Marsh KL, Varley JM . 1998 Br. J. Cancer 77: 1460–1468
Massague J, Blain SW, Lo R . 2000 Cell 103: 295–309
Robinson GW, Johnson PF, Hennighausen L, Sterneck E . 1998 Genes Dev. 12: 1907–1916
Robinson GW, Accili D, Hennighausen L . 2000 Methods in Mammary Gland Biology and Cancer Research. Ip MM and Asch BB (eds) Kluwer Academic/Plenum Publishers: New York pp 307–316
Sage J, Mulligan GJ, Attardi LD, Miller A, Chen S, Williams B, Theodorou E, Jacks T . 2000 Genes Dev. 14: 3037–3050
Serra R, Moses HL . 1995 Development 121: 3057–3066
Tzeng YJ, Guhl E, Graessmann M, Graessmann A . 1993 Oncogene 8: 1965–1971
Vooijs M, van der Valk M, te Riele H, Berns A . 1998 Oncogene 17: 1–12
Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, Li M, Furth PA, Hennighausen L . 1997 Nucleic Acids Res. 25: 4323–4330
Wang Y, Hayward SW, Donjacour AA, Young P, Jacks T, Sage J, Dahiya R, Cardiff RD, Day ML, Cunha GR . 2000 Cancer Res. 60: 6008–6017
Weinberg RS . 1995 Cell 81: 323–330
Xu X, Wagner KU, Larson D, Weaver Z, Li C, Reid T, Hennighausen L, Wynshaw-Boris A, Deng CX . 1999 Nat. Genet. 22: 37–43
Acknowledgements
We would like to thank Drs Eva Lee (University of Texas, San Antonio) for providing Rb-1Δ20 mice, and Gilbert H Smith and Robert Callahan (NCI, NIH, Bethesda) for WAP-TGFβ1 and WAP-int3 transgenic mice, respectively.
Author information
Authors and Affiliations
Corresponding author
Additional information
The article is a work of the United States Government and as such must remain in the public domain.
Rights and permissions
About this article
Cite this article
Robinson, G., Wagner, KU. & Hennighausen, L. Functional mammary gland development and oncogene-induced tumor formation are not affected by the absence of the retinoblastoma gene. Oncogene 20, 7115–7119 (2001). https://doi.org/10.1038/sj.onc.1204888
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204888